Sign Out
Use in pregnancy: Pregnancy Category X.
Rosuvastatin is contraindicated during pregnancy. If Rosuvastatin is administered to a woman with reproductive potential, she should be apprised of the potential hazard to the fetus. Rosuvastatin crosses the placenta. It is believed that HMG-CoA reductase inhibitors may decrease biologically active substances active substances derived from cholesterol and may cause fetal harm.
Lactation: Distributed into milk in animals; not known whether rosuvastatin is distributed into milk in humans. Discontinue nursing or drug, taking into account the importance of the woman.
